[EN] BICYCLIC INHIBITORS OF PAD4<br/>[FR] INHIBITEURS BICYCLIQUES DE PAD4
申请人:PADLOCK THERAPEUTICS INC
公开号:WO2017100594A1
公开(公告)日:2017-06-15
The present invention provides compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders.
本发明提供了用作PAD4抑制剂的化合物、其组合物以及治疗与PAD4相关疾病的方法。
Copper-Catalyzed Cross-Coupling Reaction of Organoboron Compounds with Primary Alkyl Halides and Pseudohalides
作者:Chu-Ting Yang、Zhen-Qi Zhang、Yu-Chen Liu、Lei Liu
DOI:10.1002/anie.201008007
日期:2011.4.18
Non‐activated alkylelectrophiles, including alkyl iodides, bromides, tosylates, mesylates, and even chlorides, underwent copper‐catalyzedcross‐coupling with aryl boron compounds and alkyl 9‐BBN reagents (see scheme; 9‐BBN=9‐borabicyclo[3.3.1]nonane). The reactions proceed with practically useful reactivities and thus complement palladium‐ and nickel‐catalyzed Suzuki–Miyaura coupling reactions of alkyl halides
[EN] PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS<br/>[FR] PROCÉDÉS DE SYNTHÈSE DE 1-ALCANOLS CHIRAUX
申请人:PURDUE RESEARCH FOUNDATION
公开号:WO2015106045A1
公开(公告)日:2015-07-16
The invention relates to highly enantioselective processes for the synthesis of chiral 1-alkanols via Zr-catalyzed asymmetric carboalumination of alkenes.
这项发明涉及通过锆催化的不对称烯烃碳铝化反应合成手性1-烷醇的高对映选择性过程。
PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS
申请人:PURDUE RESEARCH FOUNDATION
公开号:US20160332940A1
公开(公告)日:2016-11-17
The invention relates to highly enantioselective processes for the synthesis of chiral 1-alkanols via Zr-catalyzed asymmetric carboalumination of alkenes.
这项发明涉及通过Zr催化的不对称烯烃碳硼烷化反应合成手性1-烷醇的高对映选择性过程。
PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ALCOHOLS TO CORRESPONDING DIESTERS
申请人:EVONIK DEGUSSA GMBH
公开号:US20170174610A1
公开(公告)日:2017-06-22
The invention relates to a process for doubly carbonylating allyl alcohols to the corresponding diesters, wherein a linear or branched allyl alcohol is reacted with a linear or branched alkanol (alcohol) with supply of CO and in the presence of a catalytic system composed of a palladium complex and at least one organic phosphorus ligand and in the presence of a hydrogen halide selected from HCl, HBr and HI.